Primary Aldosteronism: Screening and Genetic Risk in Focus

1 source1 article First seen 5 hours ago Updated 5 hours ago United States Truth score 38

Save Like Comments Compare coverage

Summary

Genetic variants can influence tumor location, metastatic risk, treatment choices, and surveillance needs, including those of children and relatives who carry pathogenic variants. Medscape News Europe

Description from Medscape.

Who is covering this

Medscape Center Factuality: Mostly factual US 5 hours ago
Primary Aldosteronism: Screening and Genetic Risk in Focus
Genetic variants can influence tumor location, metastatic risk, treatment choices, and surveillance needs, including those of children and relatives who carry pathogenic variants. Medscape News Europe

Comments

Comments need JavaScript.

Truth score

38/100Weakly supported

Independent outlets: 1
Source reliability: 65/100
Sides of the spectrum covering it: 1/3
Propaganda risk: 0/100

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Coverage by lean

Centre 100%100%

Left: 0
Centre: 1
Right: 0
Not rated: 0

How lean is counted

Source quality

Average reliability: 65/100 (Mostly factual)
Low-credibility outlets: 0%
State media: 0%
Opinion pieces: 0%

Where ratings come from

Where the coverage comes from

United States1

In this story

Medscape News Europe

Filter the stories

Sources Ratings and details

Primary Aldosteronism: Screening and Genetic Risk in Focus

Summary

Who is covering this

Comments

Summary

Who is covering this

Comments

Related stories

Clinicians Can Break Barriers for People With Disabilities

Sleepmaxxing: Is the Pursuit of Perfect Sleep Backfiring?

Maternal FMT May Improve Post-Cesarean Infant Microbiome

Halved Antenatal Steroids Not Tied to Worse Neurodevelopment

Early Treatment May Delay Rheumatoid Arthritis

Virtual Reality Enters Multimodal Pain Care